Unifac.ddbst.at-web.biz

Dortmund Data Bank (DDB)
Data for Pharmaceuticals
Software & Separation Technology GmbH Table of Contents
Introduction.2
Data Bank Content. 2
Summary. 2Pure Component Properties.2Components.3 DDBST Software & Separation Technology GmbH Introduction
The Dortmund Data Bank contains a variety of data for pharmaceuticals like solubilities, vapor-liquid
equilibrium data and more. The purpose of this paper to to provide a statistics on available pharmaceu-
ticals and amount of available related data.
For detailed information please contact DDBST (contact information is available on the title page).
Data Bank Content
The Dortmund Data Bank contains thermodynamic data for a variety of pure pharmaceuticals and of
pharmaceuticals in mixtures with other components. The tables below give an overview on the amount
of data separated by properties.
Summary
Databank
Description
Data Sets Data Points References
Activity Coefficients at Infinite Dilution Pure Component Properties (several properties) Densities, Volumes, Volume Effects of Mixing Vapor-Liquid Equilibria (high-boiling components) 59 Vapor-Liquid Equilibria (low-boiling components) 437 DDBST Software & Separation Technology GmbH Pure Component Properties
Property
Compounds References Data Sets Data Points
DDBST Software & Separation Technology GmbH Components
CAS Registry Empirical Formula
2,2-Dichloro-1,1-difluoro-1-methoxyethane DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione 4-Amino-N-(aminoiminomethyl)benzenesulfonamide 57-67-0 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
2-Acetoxybenzoic acid <Acetylsalicylic acid> 1-Propanesulfonamide, 3-(4-nitrophenoxy)- 1-(4-Hydroxy-3-methoxyphenyl)-2-amino-ethanol 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)- DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
3-(p-Aminobenzenesulfamido)-6-methoxypyridazine 80-35-3 N-(6-Methyl-2-pyridinyl) benzenesulfonamide N1-(4,6-Dimethyl-2-pyrimidinyl)-sulfanilamide Sulfanilic acid (2,6-dimethoxy-pyrimidine-4-ylamide) 122-11-2 DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
n-(5-Bromo-8-quinolinyl)benzenesulfonamide N-(2-Methyl-4-quinolinyl)benzenesulfonamide N-(2-Methyl-8-quinolinyl)benzenesulfonamide N-(6-Methoxy-8-quinolinyl)benzenesulfonamide 6-[D-(-)-alpha-Amino-alpha-phenylacetamidol]-peni- 69-53-4 6-[Amino-(4-hydroxyphenyl)-acetamido]-penicillan DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol 11-alpha-Hydroxy-16-alpha,17-alpha-epoxyproges- DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula
21-Acetoxy-4-pregnene-11,beta,17,alpha-diol-3,20- 2-(3,4Dimethoxyphenyl)-ethyl-(3-4-(2-isopropylin- dolizine-1-sulfonyl)-phenoxypropylmethylamin DDBST Software & Separation Technology GmbH CAS Registry Empirical Formula

Source: http://unifac.ddbst.at-web.biz/tl_files/files/ddbsp/DDBSP-ListofPharmaceuticals-2007.pdf

Doi:10.1016/j.cardfail.2007.06.47

do not change during prednisone weaning, there are individual variations in response. GEP score change during prednisone weaning is not influenced by gender, age or he-modynamics. This heterogeneity in GEP response has to be borne in mind when usingthese results exclusively to guide weaning pts from prednisone following TX. Further,larger studies are needed to study this preliminary observation.

agdpiemonte.it

Legislatura 16 Atto di Sindacato Ispettivo n° 4-07990 Atto n. 4-07990 - Pubblicato il 19 luglio 2012, nella seduta n. 772 BAIO , TOMASSINI , ANDRIA , ARMATO , BIANCONI , CARLONI , CHIAROMONTE , DE FEO , DE LUCA Vincenzo , DE SENA , ESPOSITO , GARAVAGLIA Mariapia , IZZO , MARITATI , RIZZI , SBARBATI , SERRA , ZANOLETTI - Al Ministro della salute. - Lantus Insulina Glargine è un farma

Copyright © 2010-2018 Pharmacy Drugs Pdf